Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Turning tumors from cold to inflamed to improve immunotherapy response
Camille L. Gérard, Julie Delyon, Alexandre Wicky, et al.
Cancer Treatment Reviews (2021) Vol. 101, pp. 102227-102227
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 319
Dynamics and specificities of T cells in cancer immunotherapy
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 247
Magnetic–Acoustic Sequentially Actuated CAR T Cell Microrobots for Precision Navigation and In Situ Antitumor Immunoactivation
Xiaofan Tang, Ye Yang, Mingbin Zheng, et al.
Advanced Materials (2023) Vol. 35, Iss. 18
Closed Access | Times Cited: 47
Helicobacter pylori and immunotherapy for gastrointestinal cancer
Keren Jia, Chen Yang, Yi Xie, et al.
The Innovation (2024) Vol. 5, Iss. 2, pp. 100561-100561
Open Access | Times Cited: 26
Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer
Taohua Yue, Jichang Li, Jing Zhu, et al.
Cancer Research (2022) Vol. 83, Iss. 4, pp. 595-612
Open Access | Times Cited: 57
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapies
Olivier Michielin, Aly‐Khan A. Lalani, Caroline Robert, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003024-e003024
Open Access | Times Cited: 35
HSP70-Promoter-Driven CRISPR/Cas9 System Activated by Reactive Oxygen Species for Multifaceted Anticancer Immune Response and Potentiated Immunotherapy
Liang Zhao, Dongdong Li, Yuxi Zhang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 13821-13833
Closed Access | Times Cited: 33
Recent Progress in Photodynamic Immunotherapy with Metal‐Based Photosensitizers
Kai Xiong, Fangmian Wei, Yu Chen, et al.
Small Methods (2022) Vol. 7, Iss. 5
Open Access | Times Cited: 30
Current Status and Future Directions of Bacteria-Based Immunotherapy
Quan Tang, Xian Peng, Bo Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma
Zheyi Wang, Yue Zhao, Yang Wo, et al.
Cancer Letters (2024) Vol. 593, pp. 216951-216951
Closed Access | Times Cited: 8
Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy
Xin Su, Jian Li, Xiao‐Ming Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation: A review
Xiaoli Feng, Zhenhao Li, Weihong Guo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
Kejing Ma, Lin Wang, Wenhui Li, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 5
Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors
Sara Orehek, Taja Železnik Ramuta, Duško Lainšček, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1
Hongpei Tan, Jiahao Liu, Jing Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Blood–Brain Barrier Penetrating Nanovehicles for Interfering with Mitochondrial Electron Flow in Glioblastoma
Yulin Zhang, Kaiyan Xi, Yuying Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 13, pp. 9511-9524
Closed Access | Times Cited: 4
Machine learning framework develops neutrophil extracellular traps model for clinical outcome and immunotherapy response in lung adenocarcinoma
Ana Han, B. Yaping Long, Chuang Li, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 1090-1108
Closed Access | Times Cited: 4
Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
Bin Peng, Yinglin Lin, Yi Gao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma
Zihao Sun, Mingdao Hu, Xiaoning Huang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer
Rui Xu, Mengyun Wan, Jiadong Pan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Regulation of immunogenic cell death and potential applications in cancer therapy
Kun Fang, Shuai Yuan, Xue Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A novel TREM1/DAP12-based multiple chain CAR-T cell targets PTK7 in ovarian cancer therapy
Tongpeng Xu, Chen Wang, Xiaoyan Wang, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 10
Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
Tao Meng, Jing Han, Juanyi Shi, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1069-1083
Open Access | Times Cited: 10
“Internal Trouble and Outside Aggression” Strategy: Energy Deprivation Synergized With cGAS‐STING Pathway Activation for Stimuli‐Responsive Photodynamic‐Metal‐Metabolic Immunotherapy
Yanrong Qian, Yulin Xie, Guo‐Qing Zhu, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 3
Crosstalk between bladder cancer and the tumor microenvironment: Molecular mechanisms and targeted therapy
Xiaole Lu, Liang Cheng, Chenwei Yang, et al.
The Innovation Medicine (2024), pp. 100094-100094
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top